{"id":"W4408028458","doi":"10.1158/1078-0432.ccr-24-1724","title":"Health-Related Quality of Life in Patients with HR+/HER2− Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Aromatase inhibitor; Breast cancer; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Internal medicine; Oncology; Cancer; Clinical trial; Anxiety; Tamoxifen; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001687858,0.0004976314,0.0009073443,0.0001290028,0.0001445154,0.0005429532,0.000358034,0.0004372692,0.001236687],"category_scores_gemma":[0.001028326,0.000121235,0.001046443,0.0002350103,0.0002938213,0.0002971698,0.0002546226,0.000959437,0.0001826147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004060066,"about_ca_system_score_gemma":0.0003849998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003378657,"about_ca_topic_score_gemma":0.001506054,"domain_scores_codex":[0.9994473,0.0003608162,0.00003559243,0.00004835306,0.0000622743,0.00004565489],"domain_scores_gemma":[0.9995376,0.0001153583,0.0001746471,0.00003647844,0.00003089503,0.0001050358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7649733,0.007877701,0.08203017,0.002133783,0.007105584,0.0001907068,0.0001537173,0.001529838,0.008782488,0.0002310768,0.005027943,0.1199637],"study_design_scores_gemma":[0.4900219,0.134232,0.3540389,0.0003784141,0.00673562,0.0006169248,0.0001722349,0.002103409,0.002666153,0.0005318256,0.008428873,0.00007375881],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867561,0.01060894,0.0001229167,0.0004937305,0.00009226999,0.000234781,0.0005182958,0.00001166496,0.001161354],"genre_scores_gemma":[0.9946561,0.002296034,0.000237908,0.0005819157,0.0001305147,0.0004095259,0.001033025,0.000002957773,0.0006520118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001687858,"threshold_uncertainty_score":0.008926332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1187791194004468,"score_gpt":0.4719802930784011,"score_spread":0.3532011736779543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}